United States Radiopharmaceuticals Market 2025 | Opportunity Map for Pharma Companies and Healthcare Investors

DataM Intelligence has published a new research report on "Radiopharmaceuticals Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/radiopharmaceuticals-market?kb

Latest M & A

• Bristol Myers Squibb completes acquisition of RayzeBio, adding an actinium‐based radiopharmaceutical platform to its oncology portfolio ($4.1B).
• AstraZeneca agrees to acquire Fusion Pharmaceuticals in a strategic radiopharmaceuticals buyout worth up to $2.4B.

• Novartis to acquire Mariana Oncology for up to $1.75B to expand radioligand therapy capabilities.

• GE HealthCare acquires full ownership of Nihon Medi‐Physics, strengthening its radiopharma imaging agents business.

• Telix Pharmaceuticals completes acquisition of RLS (USA) Inc., enhancing its radiopharmacy network across the U.S.

• SHINE Technologies acquires Lantheus's SPECT business line, expanding its diagnostic radiopharmaceuticals portfolio.

Key Players:

Novartis Pharmaceuticals Corporation, Bayer Corporation, Jubilant DraxImage Inc., Eckert & Ziegler, Telix Pharmaceuticals Limited, and Eli Lilly and Company

Key Development:

Jan 2026:

FDA approves a novel targeted alpha therapy for metastatic prostate cancer, enhancing treatment options.

Major pharmaceutical company announces a $200M investment in next-gen radiotracer research.

Collaborative research launched between leading universities to develop safer, more efficient radiopharmaceutical delivery systems.

Dec 2025:

Introduction of a new PET imaging agent that significantly improves early detection of neurological disorders.

Regulatory bodies streamline approval processes for emerging radiopharmaceuticals to speed patient access.

Industry leaders convene at the Global Radiopharma Summit to discuss sustainable isotope production.

Nov 2025:

Breakthrough in radiolabeling technology reduces production costs by 30%, improving market accessibility.

Launch of AI-driven platforms to optimize radiopharmaceutical dosage and personalize treatment plans.

Partnerships announced between biotech firms and hospitals to expand clinical trial networks worldwide.

Growth Forecast Projected:

The Global Radiopharmaceuticals Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Radiopharmaceuticals Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=radiopharmaceuticals-market?kb

Key Segments:

By Type: Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals

By Radioisotope: Technetium-99m, Fluorine-18, Gallium-68, Gallium-67, Iodine-131, Lutetium-177, Yttrium-90 and Others

By Indication: Prostate Cancer, Neuroendocrine Tumors, Thyroid Cancer, Bone Tumors, Hyperthyroidism, Myocardial Perfusion, Pulmonary Perfusion, Vascular Perfusion and Others

By End-User: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Academic & Research Institutes and Others

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/radiopharmaceuticals-market?kb

FAQ

Q1: What is the current size of the Radiopharmaceuticals Market?

A: The Radiopharmaceuticals Market was valued at US$ 7.91 billion in 2024 and is forecasted to reach US$ 19.69 billion by 2033

Q2: How rapidly will the Market expand?

A: The Radiopharmaceuticals market is projected to grow at a CAGR of 10.8% between 2025 and 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.